2022
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 19 Aug 2022 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 360,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 16 Aug 2022 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 1,920,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
NIU’EIKI HOSPITAL GOES LIVE ON VESALIUS
12 Aug 2022 – Our congratulations to Ministry of Health, Tonga for the successful deployment of VESALIUS Hospital Information & Electronic Medical Record Systems in Niu’eiki Hospital on ‘Eua Island. This roll-out is part of a Nationwide Health Information System (HIS) and Electronic Medical Record (EMR) project for the Kingdom of Tonga funded by Asian Development Bank. The project spans…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 11 Aug 2022 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 300,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
EYRIS CO-FOUNDER RECEIVES ARVO ACHIEVEMENT AWARD
10 Aug 2022 – Our heartiest congratulations to our co-founder of EyRIS Prof Wong Tien Yin for being awarded the ARVO Achievement Award – Friedenwald Award 2023 by the Association for Research in Vision and Ophthalmology (ARVO). This award honours clinical research in ophthalmology and pays tribute to Dr Jonas S. Friedenwald, who made numerous contributions to the field. Distinguished…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 04 Aug 2022 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 200,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
Annual Report & CG Report
NOVA MSC BERHAD 29 Jul 2022 Annual Report for Financial Year Ended 31 Mar 2022 Subject Annual Report & CG Report – 2022 Please refer attachment below. Nova MSC – CG Report 2022 Nova MSC 2022 – Bursa
GENERAL MEETINGS: Notice of Meeting
NOVA MSC BERHAD 28 Jul 2022 Type of Meeting General Indicator Notice of Meeting Description Notice of the Twentieth (20th) Annual General Meeting Date of Meeting 07 Sep 2022 Time 03:00 PM Venue(s) A fully virtual meeting via online meeting platform of Vote2u e-Portal at https://web.vote2u.my (Domain Registration No. with MyNIC: D6A471702) provided by Agmo Digital Solutions Sdn. Bhd….
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016)
NOVA MSC BERHAD 20 Jul 2022 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 19 Jul 2022 800,800 Acquired Direct Interest Name of registered holder Alliancegroup Nominees (Tempatan) Sdn Bhd Pledged Securities Account…
EYRIS FEATURED ON MEDIACORP CHANNEL 8 TO SHOWCASE THE CHRONIC KIDNEY DISEASE DETECTION ALGORITHM
14 Jul 2022 – EyRIS recently had the opportunity to showcase her latest innovation, RetiKid, on Mediacorp Channel 8 Primetime News segment. RetiKid is a deep learning algorithm that is able to detect Stage 3 and above chronic kidney disease (CKD) using retinal fundus images, without the need to draw any blood from the patient. RetiKid can be marketed in…
Additional Listing Announcement /Subdivision of Shares
NOVA MSC BERHAD 22 Jun 2022 1. Details of Corporate Proposal Involve issuance of new type/class of securities ? No Types of corporate proposal Conversion of Preference Shares Details of corporate proposal Conversion of Irredeemable Convertible Preference Shares No. of shares issued under this corporate proposal 60,000 Issue price per share ($$) Malaysian Ringgit (MYR) 0.0400 Par Value($$) (if…
Changes in Sub. S-hldr’s Int (Section 138 of CA 2016)
NOVA MSC BERHAD 17 Jun 2022 Particulars of substantial Securities Holder Name MR OOI KENG THYE Nationality/Country of incorporation Malaysia Descriptions (Class) Ordinary shares Details of changes No Date of change No of securities Type of Transaction Nature of Interest 1 15 Jun 2022 1,170,000 Acquired Direct Interest Name of registered holder Alliancegroup Nominees (Tempatan) Sdn Bhd Pledged Securities Account…